Skip to main content
. 2021 Jul 4;36(11):4256–4264. doi: 10.1111/jocs.15785

Table 3.

Inflammatory, metabolic, and clinical data after 72‐h CytoSorb treatment, or parallel interval on ECMO alone

Variable VV‐ECMO + CytoSorb, n = 10
Pre Post % change*
Lactate dehydrogenase, U/L, median (IQR) 856 (718–1115) 425 (370–644) −49 (−61 to −31)
Ferritin, ng/ml, median (IQR) 2647 (1306–2815) 1004 (576–2031) −46 (−62 to −41)
d‐Dimer, ng/ml, median (IQR) 5517 (2619–9363) 4188 (2911–8810) −7 (−22 to 0)
C‐reactive protein, mg/dL, median (IQR) 117 (31–263) 64 (7.8–105) −55 (−75 to −47)
Procalcintonin, ng/ml, median (IQR) 1.2 (0.21–3.8) 0.19 (0.08–15) −76 (−100 to −51)
Lactate, mmol/L, median (IQR) 1.60 (1.32–2.55) 1.35 (1.08–1.53) −44 (−63 to −9.4)
IL‐2R, pg/ml, median (IQR) 2143 (1147–15201) 1279 (1097–2293) −54 (−100 to −4.3)
IL‐6, pg/ml, median (IQR) 22 (9–618) 11 (7–146) −86 (−100 to −31)
IL‐10, pg/ml, median (IQR) 18 (9.5–73) 5 (5–83) −64 (−100 to −27)
Hemotocrit, %, median (IQR) 33 (30–36) 30 (27–32) −9 (−14 to 8.3)
Absolute lymphocyte count, 1000/µl, median (IQR) 5 (1.5–5) 6 (4–11) +140 (0 to 280)
Platelet count, 1000/µl, median (IQR) 215 (138–262) 94 (35–138) −60 (−76 to −25)
Aspartate aminotransferase, U/L, median (IQR) 39 (26–66) 28 (21–79) −10 (−43 to −2.6)
Alanine aminotransferase, U/L, median (IQR) 41 (25–72) 23 (20–56) −40 (−42 to −10)
Creatinine, mg/dL, median (IQR) 1.1 (0.8–2.3) 1.4 (0.6–1.8) −7 (−21 to 13)
pH, median (IQR) 7.38 (7.28–7.42 7.42 (7.37–7.44) 1 (0.3 to 1)
PCO2, mm Hg, median (IQR) 42 (41–51) 43 (41–44) −1 (−13 to 10)
FiO2, %, median (IQR) 40 (40–40) 40 (40–45) 0 (0 to 12.5)
PaO2/FiO2 (P:F ratio), median (IQR) 185 (152–225) 185 (170–260) −9 (−34 to 6)
Vasopressin inotropic score, median (IQR) 4.52 (0–12.25) 1 (0–2.68) −80 (−91 to −36)

Abbreviations: FiO2, fraction of inspired oxygen; IL, interleukin; PCO2, partial pressure of carbon dioxide.

*

Grouped %change reported as per individual patient as (72 h – Pre)/Pre, mean of change p < .05.